ProfileGDS4718 / 200857_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 90% 83% 87% 87% 74% 75% 86% 88% 88% 85% 87% 83% 70% 82% 84% 87% 77% 83% 78% 88% 86% 88% 87% 85% 77% 84% 81% 88% 71% 75% 78% 87% 88% 73% 78% 75% 84% 85% 86% 88% 73% 80% 76% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.6544686
GSM549102patient 115, normal, homogenized [OPG study]9.0699290
GSM549104patient 119, normal, homogenized [OPG study]8.3247883
GSM549108patient 138, normal, homogenized [OPG study]8.7014187
GSM549119patient 077, normal, homogenized [OPG study]8.6636787
GSM549133patient 032, cancer, homogenized [OPG study]7.3545774
GSM549139patient 042, cancer, homogenized [OPG study]7.3894875
GSM549099patient 107, normal, homogenized [OPG study]8.545586
GSM549109patient 139, normal, homogenized [OPG study]8.8781988
GSM549110patient 046, normal, homogenized [OPG study]8.8313388
GSM549114patient 063, normal, homogenized [OPG study]8.5722885
GSM549122patient 082, normal, homogenized [OPG study]8.7657887
GSM549134patient 033, cancer, homogenized [OPG study]8.2265583
GSM549136patient 036, cancer, homogenized [OPG study]6.9452270
GSM549140patient 044, cancer, homogenized [OPG study]8.1587582
GSM549111patient 047, normal, homogenized [OPG study]8.4701284
GSM549113patient 057, normal, homogenized [OPG study]8.8435287
GSM549132patient 031, cancer, homogenized [OPG study]7.600977
GSM549137patient 038, cancer, homogenized [OPG study]8.2024383
GSM549142patient 047, cancer, homogenized [OPG study]7.4163178
GSM549100patient 110, normal, homogenized [OPG study]8.8872788
GSM549107patient 135, normal, homogenized [OPG study]8.65786
GSM549115patient 068, normal, homogenized [OPG study]9.1464988
GSM549116patient 072, normal, homogenized [OPG study]8.852487
GSM549120patient 078, normal, homogenized [OPG study]8.4665685
GSM549131patient 030, cancer, homogenized [OPG study]7.6821377
GSM549118patient 074, normal, homogenized [OPG study]8.3564484
GSM549129patient 027, cancer, homogenized [OPG study]7.9803481
GSM549123patient 088, normal, homogenized [OPG study]8.8625188
GSM549124patient 006, cancer, homogenized [OPG study]6.8922571
GSM549126patient 015, cancer, homogenized [OPG study]7.3807275
GSM549128patient 025, cancer, homogenized [OPG study]7.6876578
GSM549103patient 117, normal, homogenized [OPG study]8.555387
GSM549117patient 073, normal, homogenized [OPG study]9.0894188
GSM549138patient 041, cancer, homogenized [OPG study]7.1497673
GSM549141patient 045, cancer, homogenized [OPG study]7.7224678
GSM549130patient 028, cancer, homogenized [OPG study]7.3431375
GSM549101patient 111, normal, homogenized [OPG study]8.3481984
GSM549105patient 128, normal, homogenized [OPG study]8.4036685
GSM549106patient 134, normal, homogenized [OPG study]8.6973886
GSM549112patient 048, normal, homogenized [OPG study]8.9047288
GSM549125patient 011, cancer, homogenized [OPG study]7.1409873
GSM549127patient 024, cancer, homogenized [OPG study]7.858580
GSM549135patient 035, cancer, homogenized [OPG study]7.5057476